Desh Rakshak Aushdhalaya (BOM:531521) ROCE %: 12.20% (As of Mar. 2026)

What is Desh Rakshak Aushdhalaya ROCE %?

Desh Rakshak Aushdhalaya BOM:531521 67 ROCE % is 12.20% as of Mar. 2026. GuruFocus rates BOM:531521 with a GF Score™ of 67/100 and a GF Value™ of ₹18.42 (Significantly Overvalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Desh Rakshak Aushdhalaya's annualized ROCE % for the quarter that ended in Mar. 2026 was 12.20%.

Desh Rakshak Aushdhalaya (BOM:531521) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Desh Rakshak Aushdhalaya ROCE % Related Terms

Desh Rakshak Aushdhalaya ROCE % Historical Data

* Premium members only.

The historical data trend for Desh Rakshak Aushdhalaya's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Desh Rakshak Aushdhalaya ROCE % Chart

Desh Rakshak Aushdhalaya Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

ROCE %

Get a 7-Day Free Trial

6.15

6.59

6.75

6.81

6.49

Desh Rakshak Aushdhalaya Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															20.31	4.60	4.25	4.01	12.20

67GF Score

Desh Rakshak Aushdhalaya Ltd BOM:531521

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Desh Rakshak Aushdhalaya ROCE % Calculation

Desh Rakshak Aushdhalaya's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	9.592	/	( ( (179.761 - 49.389)	+	(208.884 - 43.583) )	/ 2 )
	=	9.592	/	( (130.372	+	165.301)	/ 2 )
	=	9.592	/	147.8365
	=	6.49 %

Desh Rakshak Aushdhalaya's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	20.164	/	( ( (0 - 0)	+	(208.884 - 43.583) )	/ 1 )
	=	20.164	/	( ( 0	+	165.301 )	/ 1 )
	=	20.164	/	165.301
	=	12.20 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 12.20% mean?

Desh Rakshak Aushdhalaya (BOM:531521) has a ROCE % of 12.20% as of Mar. 2026.

Is Desh Rakshak Aushdhalaya's ROCE % too high?

Desh Rakshak Aushdhalaya's current ROCE % is 12.20%. The Drug Manufacturers industry median ROCE % is 7.04. Desh Rakshak Aushdhalaya's value of 12.20% is 73.3% above this industry median. Overall, Desh Rakshak Aushdhalaya has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Desh Rakshak Aushdhalaya's ROCE % compare to ZTS and UTHR?

Desh Rakshak Aushdhalaya's ROCE % of 12.20% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.04. Desh Rakshak Aushdhalaya's value of 12.20% is 73.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Drug Manufacturers company?

The median ROCE % among Drug Manufacturers companies is 7.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Desh Rakshak Aushdhalaya's current ROCE % of 12.20% is 73.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Desh Rakshak Aushdhalaya's current ROCE % is 12.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Desh Rakshak Aushdhalaya stock overvalued right now?

Based on GuruFocus' analysis, Desh Rakshak Aushdhalaya (BOM:531521) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹18.42, compared to a current price of ₹32.59 — trading 76.9% above its estimated fair value. The current ROCE % is 12.20% and 73.3% above the Drug Manufacturers industry median of 7.04. Desh Rakshak Aushdhalaya's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Desh Rakshak Aushdhalaya (BOM:531521), the current ROCE % is 12.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Desh Rakshak Aushdhalaya (BOM:531521) Overvalued in 2026?

Based on GuruFocus' analysis, Desh Rakshak Aushdhalaya stock appears to be overvalued. The current stock price of ₹32.59 is trading 76.9% above its estimated GF Value™ of ₹18.42. GuruFocus considers Desh Rakshak Aushdhalaya to be Significantly Overvalued.

Key valuation signals for BOM:531521:

ROCE %: 12.20%
GF Value™: ₹18.42 vs. price of ₹32.59 (76.9% above fair value)
GF Score™: 67/100 with 5 warning signs
Industry Position: 73.3% above the Drug Manufacturers median

No single metric tells the full story. See the BOM:531521 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Desh Rakshak Aushdhalaya Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies BOM:531210 BOM:526075 BOM:530665 BOM:524400 BOM:531015 BOM:539287 BOM:539561 NSE:SAROJA BOM:524768 BOM:524314 XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Address Bhagwant Kuti, Kankhal, Haridwar, UT, IND, 249408

Website https://www.deshrakshak.in

Desh Rakshak Aushdhalaya Ltd manufactures and sells ayurvedic and herbal products in India. The firm offers ayurvedic patents & proprietary medicines with herbs. It provides classical and patent medicines in tablet and capsule, powder, and liquid forms. Products ranging from AmalkiChurna, Ashwagandha Tablet, TriphalaChurna, LavanaBhaskarChurna, Sat-Shilajeet, ShunthiChurna, HingwadiChurna, GasharVati, BuddhivardhakYog, Balamrit, LodhraChurna, and Others.

67GF Score

Get the complete analysis for BOM:531521

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹32.59

Price

₹18.42

GF Value

View BOM:531521 Analysis

See ROCE % data for all stocks →